From December 1, 2022 to February 28, 2023, the company has repurchased 91,171 shares, representing 0.33% for KRW 434.14 million. With this, the company has completed the repurchase of 436,008 shares, representing 1.57% for KRW 1,960.45 million under the buyback announced on June 23, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,655 KRW | -0.41% | -1.88% | -11.07% |
2023 | Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023. | CI |
2023 | Hyundai Pharmaceutical Co., Ltd.(KOSE:A004310) dropped from S&P Global BMI Index | CI |
1st Jan change | Capi. | |
---|---|---|
-11.07% | 73.9M | |
+18.09% | 41.07B | |
+24.16% | 22.65B | |
+15.71% | 15.02B | |
+20.11% | 14.14B | |
+52.15% | 12.09B | |
-10.97% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+15.28% | 5.59B |
- Stock Market
- Equities
- A004310 Stock
- News Hyundai Pharmaceutical Co., Ltd.
- Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 23, 2022.